Clinical Trial Update: Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 Diabetes [Phase 4]

View source ↗

Summary

This Phase 4 trial update evaluates the effect of rosiglitazone on carotid intima-media thickness in patients with insulin resistance syndrome and/or type 2 dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED